Constellium (CSTM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Q3 2025 revenue rose 20% year-over-year to $2.2 billion, with net income surging to $88 million from $8 million in Q3 2024, driven by higher shipments and improved pricing across all segments.
Adjusted EBITDA reached $235 million (up 85% year-over-year), including a $39 million non-cash metal price lag benefit.
All three operating segments reported higher revenues and improved Adjusted EBITDA, with AS&I showing the largest percentage gain.
Free Cash Flow for Q3 was $30 million, with $68 million year-to-date and $75 million spent on share repurchases.
Ingrid Joerg appointed as CEO effective January 2026, succeeding Jean-Marc Germain.
Financial highlights
Shipments rose 6% year-over-year to 373,000 tons; Q3 revenue: $2.2 billion (+20% YoY); net income: $88 million (vs. $8 million in Q3 2024); EPS: $0.63 basic.
Adjusted EBITDA for Q3: $235 million (up from $127 million in Q3 2024); nine-month Adjusted EBITDA: $566 million.
Free Cash Flow: $30 million for Q3; $68 million year-to-date.
Share repurchases: 1.7 million shares in Q3 for $25 million; 6.5 million shares YTD for $75 million.
Leverage at 3.1x as of September 30, 2025; liquidity at $831 million; net debt at $1.89 billion.
Outlook and guidance
2025 guidance raised: Adjusted EBITDA (excluding metal price lag) targeted at $670–$690 million and Free Cash Flow in excess of $120 million.
Long-term targets reaffirmed: Adjusted EBITDA of $900 million and Free Cash Flow of $300 million by 2028.
Guidance incorporates tariff impacts, customer compensations, improved scrap spreads, and modest benefit from supply chain disruptions.
Latest events from Constellium
- Record 2025 results, strong cash flow, reduced leverage, and Vision 2028 launched.CSTM
Q4 202518 Feb 2026 - Net income more than doubled despite Swiss flooding, with 2025 EBITDA target reaffirmed.CSTM
Q2 20243 Feb 2026 - Q3 2024 results were hit by lower volumes, flood losses, and weak demand across key markets.CSTM
Q3 202419 Jan 2026 - 2024 saw lower results from disruptions, but 2025–2028 targets reflect recovery and growth.CSTM
Q4 20246 Jan 2026 - Revenue and net income rose in Q1 2025, with guidance for the year reaffirmed.CSTM
Q1 202524 Dec 2025 - 2025 guidance raised as revenue grows but net income declines on margin pressure.CSTM
Q2 202516 Nov 2025